Skip to content

A clinical stuudy to know the effect of bhadramustadi churna in treatment of kaphaja kasa

A Randomized Controlled Clinical Study To Evaluate The Efficacy Of Bhadramustadi Churna In Kaphaja Kasa - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104371
Enrollment
40
Registered
2026-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J202- Acute bronchitis due to streptococcus

Interventions

None listed

Sponsors

Dr Kran Madhukar Chandanshive
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects irrespective of gender, religion and socio economic status aged between 06 to 12 years. 2 . Subjects with Snigdha Nishthivana and Ghana Kapha and with or without other symptoms of kaphaja kasa 3 . Kaphaja Kasa of less than 7 days duration will be selected.

Exclusion criteria

Exclusion criteria: Subjects will be excluded with Kaphaja Kasa a s a Anubandha Lakshana or Upadrava after observing the clinical symptoms. 2 . Subjects will b e excluded with any other systematic disease after observing clinical symptoms. 3 . If any history of Adverse Drug Reaction priorly and any Adverse Drug Reaction i s reported in between the study duration.

Design outcomes

Primary

MeasureTime frame
Subjects will be assessed to observe the improvement in Cough, Number of bouts of cough in one hour, Throat congestion, Nasal dischargeTimepoint: Before treatment, on the 4th day, 8th day and 15th day.

Secondary

MeasureTime frame
To reduce the repeated occurrence of coughTimepoint: Before treatment, on the 4th day, 8th day and 15th day.

Countries

India

Contacts

Public ContactDr Jithesh Chowta

Alvas ayurveda medical college and hospital

jitheshchowta@gmail.com9164123167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026